Probiotics, prebiotics, and postbiotics in health and disease

Abstract

The gut microbiota and its homeostasis play a crucial role in human health. However, for some diseases related to the gut microbiota, current traditional medicines can only relieve symptoms, and it is difficult to solve the root causes or even cause side effects like disturbances in the gut microbiota. Increasing clinical studies and evidences have demonstrated that probiotics, prebiotics, and postbiotics can prevent and treat various diseases, but currently they can only be used as dietary supplements rather than medicines, which restricts the application of probiotics in the field of medicine. Here, this review analyzes the importance of gut microbiota in human health and the current problems of traditional medicines, and systematically summarizes the effectiveness and mechanisms of probiotics, prebiotics, and postbiotics in maintaining health and treating diseases based on animal models and clinical trials. And based on current research outcomes and development trends in this field, the challenges and prospects of their clinical application in maintaining health, alleviating and treating diseases are analyzed. It is hoped to promote the application of probiotics, prebiotics, and postbiotics in disease treatment and open up new frontiers in probiotic research.

Does “all disease begin in the gut”? The gut-organ cross talk in the microbiome

“…The promotion of gut health through dietary interventions, probiotics, and prebiotics has emerged as a promising therapeutic approach for alleviating skin diseases (Ji et al 2023 ).…”

Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets

“…Nevertheless, since probiotics are categorized only as nutraceuticals and not as drugs, public acceptance and regulatory rules have also limited their use in the clinical field [ 103 ]. Until recently, some researchers have suggested proposing the term “probacine” (PRObiotic BActerial mediCINE) emphasizes the role of probiotics in the prevention, alleviation, and treating diseases, and further promotes the clinical application of probiotics [ 104 ]. Therefore, the use of probiotics in clinical medicine to improve NAFLD can be seen as a promising prospect.…”

Unraveling the antimicrobial potential of Lactiplantibacillus plantarum strains TE0907 and TE1809 sourced from Bufo gargarizans: advancing the frontier of probiotic-based therapeutics

“…Numerous studies have focused on investigating the potential impact of L. plantarum in managing diverse gastrointestinal disorders, including infectious diarrhea, antibiotic-associated diarrhea, irritable bowel syndrome (IBS), and inflammatory bowel disease (Ji et al, 2023 ; Kumar et al, 2023 ; Yang et al, 2023 ). L. plantarum 299v ameliorated Escherichia coli -induced intestinal permeability in rats, mitigating a 53% surge in mannitol permeation through the intestinal barrier, as gauged using Ussing chambers (Mangell et al, 2002 ).…”